Firanescu, Cristina E. http://orcid.org/0000-0002-0332-5025
de Vries, Jolanda
Lodder, Paul
Schoemaker, Marinus C.
Smeets, Albert J.
Donga, Esther
Juttmann, Job R.
Klazen, Caroline A. H.
Elgersma, Otto E. H.
Jansen, Frits H.
van der Horst, Irene
Blonk, Marion
Venmans, Alexander
Lohle, Paul N. M.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Percutaneous Vertebroplasty is no Risk Factor for New Vertebral Fractures and Protects Against Further Height Loss (VERTOS IV)
https://doi.org/10.1007/s00270-019-02205-w
Funding for this research was provided by:
Stryker (S-I-013)
Article History
Received: 13 November 2018
Accepted: 11 March 2019
First Online: 2 April 2019
Compliance with Ethical Standards
:
: The authors declare that they have no competing interest.
: The procedures were in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This trial was an institutional review board-approved sham-controlled, double-blind, multicentre, randomised trial performed at four community hospitals in the Netherlands (MN-11-004, approval protocol 1055).